L’Oreal Settles Deceptive Advertising Suit with the Federal Trade Commission

Home » Blog »


Share on facebook
Share on twitter
Share on linkedin

Get a Free Compliance Review

Our trusted legal counsel can help ensure your business stays compliant.
  • This field is for validation purposes and should be left unchanged.
Print Friendly, PDF & Email

blogpostpic4-24On June 30, 2014, the Federal Trade Commission (“FTC”) issued a press release announcing that it had entered into a settlement with cosmetic manufacturer L’Oreal USA (“L’Oreal”).  Following an investigation and prior to entering into the settlement, the FTC was prepared to file a complaint alleging that L’Oreal had deceptively advertised that certain of its products provided “anti-aging” benefits to consumers.  These claims were unsubstantiated by L’Oreal and, the FTC alleged, based on flawed consumer satisfaction surveys.  Although there is no monetary penalty, L’Oreal will be bound by the terms of its settlement with the FTC for the next twenty (20) years.

L’Oreal’s Alleged Deceptive Advertising

The FTC’s complaint against L’Oreal alleged that between February 2009 and April 2013, L’Oreal advertised that its Lancome Genifique products were “clinically proven” to produce “perfectly luminous” skin by boosting gene activity in consumers.  L’Oreal made similar claims in connection with the advertising of another one of its products.  However, the clinical “proof” L’Oreal relied on to make such claims was produced from questionnaires that it had sent to 34 consumers with, as the FTC alleged, ambiguous questions designed to elicit misleading responses.  The FTC alleged that L’Oreal’s advertising of these two particular products was deceptive, misleading and false, and that “[i]n fact, scientific studies do not prove the representations” made by L’Oreal in its advertising.

The Settlement

L’Oreal has agreed that it will no longer make any advertising claims that its products boost gene activity to make skin look or act younger, or that its products respond faster to aggressors like stress, fatigue and aging, “unless the company has competent and reliable scientific evidence substantiating such claims.”  L’Oreal has also agreed to cease making advertising claims about its products that misrepresent the results of any test or study.

The settlement agreement is subject to public comment until July 30, 2014.  Thereafter, the FTC will decide whether to give the settlement agreement final approval.

Protect Yourself

As we have previously noted, the FTC has been aggressively monitoring and targeting the marketing practices of United States manufacturers, resulting in some substantial monetary judgments.  (See FTC Settles Deceptive Advertising Lawsuit with Mobile Marketer for $4 Million, FTC Awarded Full Amount of Net Sales in False Advertising Lawsuit).  The FTC has been especially watchful of deceptive advertising used to promote consumer heath related products (See FTC Aggressively Targeting Health Supplement Advertising, Marketers of Weight-Loss Products Targeted by FTC).    

If you are interested in reviewing your marketing practices, or if you have been served with legal process relating to same, please e-mail us at info@kleinmoynihan.com or call us at (212) 246-0900.

The material contained herein is provided for informational purposes only and is not legal advice, nor is it a substitute for obtaining legal advice from an attorney.  Each situation is unique, and you should not act or rely on any information contained herein without seeking the advice of an experienced attorney.

Attorney Advertising

Trending Topics

SMS Text Messages and the TCPA- Klein Moynihan Turco LLP

SMS Text Messaging and the TCPA

Print Friendly, PDF & Email

Short Message Service (SMS) text messaging has become a ubiquitous form of communication for people over the last decade.  Consequently, marketers and advertisers who are

Read More »